Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Cost of Revenue: 2019-2024

Historic Cost of Revenue for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $34.9 million.

  • MDxHealth's Cost of Revenue rose 5.71% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 million, marking a year-over-year increase of 12.94%. This contributed to the annual value of $34.9 million for FY2024, which is 32.91% up from last year.
  • Per MDxHealth's latest filing, its Cost of Revenue stood at $34.9 million for FY2024, which was up 32.91% from $26.3 million recorded in FY2023.
  • MDxHealth's Cost of Revenue's 5-year high stood at $34.9 million during FY2024, with a 5-year trough of $10.4 million in FY2020.
  • Its 3-year average for Cost of Revenue is $26.3 million, with a median of $26.3 million in 2023.
  • Per our database at Business Quant, MDxHealth's Cost of Revenue dropped by 11.39% in 2020 and then surged by 52.76% in 2022.
  • MDxHealth's Cost of Revenue (MRY) stood at $10.4 million in 2020, then increased by 12.09% to $11.7 million in 2021, then surged by 52.76% to $17.8 million in 2022, then skyrocketed by 47.26% to $26.3 million in 2023, then soared by 32.91% to $34.9 million in 2024.
  • Its last three reported values are $34.9 million in FY2024, $26.3 million for FY2023, and $17.8 million during FY2022.